Australian biotech market today 23.04.09

By Kate McDonald
Thursday, 23 April, 2009

A very flat day’s trading on the healthcare index today, in line with the rest of stocks, which were generally in the positive but volumes were small.

Biota (ASX:BTA) is up 12c on news that royalties from Relenza for the quarter will total $32.3 million.

Circadian (ASX:CIR) was up 3c, as was Clinuvel (ASX:CLV), up 2c to 32c.

Cochlear (ASX:COH) was substantially down again, to $48.3, while Pharmaxis (ASX:PXS) was up a touch.

Diversa (ASX:DVA) was up slightly on its reinstatement to trading.

Related News

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd